What Does FUJIFILM Diosynth Biotechnologies Do?

Total employees5184
HeadquartersHolly Springs
Founded2011

Fujifilm Diosynth Biotechnologies (FDB) is a globally recognized Contract Development and Manufacturing Organization (CDMO) specializing in the development and manufacturing of biologics, vaccines, gene therapies, and other advanced biopharmaceuticals. With state-of-the-art facilities and decades of experience, FDB partners with pharmaceutical and biotech companies worldwide to bring innovative medicines to patients. Their services span from cell line development, process and analytical development, to clinical and commercial cGMP manufacturing, leveraging expertise in microbial, mammalian, and viral-based production systems.

Where Is FUJIFILM Diosynth Biotechnologies's Headquarters?

HQ Function

Large-scale contract development and manufacturing (CDMO) of biologics, including monoclonal antibodies via cell culture, microbial fermentation products, and gene therapies. Serves as a strategic site for end-to-end biopharmaceutical production and innovation.

Notable Features:

State-of-the-art, highly automated facility designed for sustainability and efficiency. Set to be North America’s largest end-to-end biopharmaceutical manufacturing facility, featuring multiple 20,000L bioreactors.

Work Culture:

The work culture at Fujifilm Diosynth Biotechnologies, including its Holly Springs site, emphasizes innovation, quality, patient focus, and collaboration. Employees often highlight a commitment to scientific excellence, continuous improvement, and a 'Partners for Life' philosophy with clients. There's a strong sense of purpose tied to advancing human health.

HQ Significance:

The Holly Springs facility is a cornerstone of Fujifilm's multi-billion dollar investment in expanding its Bio CDMO business. It significantly enhances FDB's capacity to meet the growing global demand for advanced therapies and vaccines, positioning it as a key player in the biopharmaceutical supply chain.

Values Reflected in HQ: The Holly Springs headquarters reflects Fujifilm's values of innovation (advanced manufacturing technologies), commitment to health (producing life-saving medicines), sustainability (eco-friendly design and operations), and long-term growth (significant investment in future capacity).

Location:

Fujifilm Diosynth Biotechnologies maintains a robust global presence with strategically located cGMP manufacturing and development facilities in the United States (North Carolina, Texas, California), the United Kingdom (Billingham), and Denmark (Hillerød). This international network enables the company to provide comprehensive, end-to-end services—from cell line and process development through to clinical and commercial scale manufacturing of biologics, vaccines, and advanced therapies (gene and cell therapies)—to a diverse global client base in the pharmaceutical and biotechnology industries.

Street Address:

5501 FUJIFILM Way

City:

Holly Springs

State/Province:

North Carolina

Country:

USA

Where Else Does FUJIFILM Diosynth Biotechnologies Operate Around the World?

Billingham, United Kingdom

Address: Belasis Avenue, Billingham, TS23 1LH, UK

Serves as a major European hub for microbial-based biomanufacturing, viral product development, and cell and gene therapy services, supporting clients globally.

Hillerød, Denmark

Address: Biotek Allé 1, DK-3400 Hillerød, Denmark

Strengthens FDB's European presence for large-scale commercial manufacturing of mammalian cell culture-derived biologics, supporting global supply chains for advanced therapies.

College Station, Texas, USA

Address: 3939 Biomedical Way, College Station, TX 77845, USA

A critical U.S. site for the development and manufacturing of gene therapies and viral products, catering to the rapidly growing advanced therapies market and national preparedness needs.

Research Triangle Park (RTP), North Carolina, USA

Address: Multiple locations within RTP, e.g., 6051 George Watts Hill Dr, Research Triangle Park, NC 27709, USA

Serves as a core R&D and manufacturing center in North America, leveraging the rich biotech ecosystem of the Research Triangle region to support global clients.

Thousand Oaks, California, USA

Address: 2345 W. Wuthrich Ave, Thousand Oaks, CA 91320, USA

Provides critical downstream drug product capabilities on the U.S. West Coast, complementing FDB's drug substance manufacturing network.

Buying Intent Signals for FUJIFILM Diosynth Biotechnologies

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading FUJIFILM Diosynth Biotechnologies? Meet the Executive Team

As of April 2025, FUJIFILM Diosynth Biotechnologies' leadership includes:

Martin Meeson - Chief Executive Officer
Christine G. Flood - Chief Financial Officer
Gerry Farrell - Chief Operating Officer - U.S. Sites & Site Head, Holly Springs
Lee Kingsbury - Chief Operating Officer - Europe
Lars Petersen - Chief Operating Officer - Large Scale
Andy Fenwick - Chief Business Officer
Kenneth Bilen - Chief Quality Officer
Sarah Holland - Chief Human Resources Officer
Richard McAvoy - Chief Legal Officer & Corporate Secretary
Jonathan Haigh - Chief Information Officer

Who's Investing in FUJIFILM Diosynth Biotechnologies?

FUJIFILM Diosynth Biotechnologies has been backed by several prominent investors over the years, including:

Fujifilm Holdings Corporation (Parent Company)

What Leadership Changes Has FUJIFILM Diosynth Biotechnologies Seen Recently?

Hire1
Exits0

In the past 12 months, Fujifilm Diosynth Biotechnologies has continued to strengthen its leadership team with key appointments, such as the Chief Quality & Compliance Officer, reflecting its commitment to operational excellence and growth. Other executive roles have evolved to support the company's expanding global operations and strategic initiatives. No major C-level departures have been publicly announced.

New Appointments:

Kenneth Bilen, Kenneth Bilen joined Fujifilm Diosynth Biotechnologies as Chief Quality & Compliance Officer, bringing extensive experience in biopharmaceutical quality management to oversee and enhance the company's global quality systems and compliance standards.

What Technology (Tech Stack) Is Used byFUJIFILM Diosynth Biotechnologies?

Discover the tools FUJIFILM Diosynth Biotechnologies uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

FUJIFILM Diosynth Biotechnologies Email Formats and Examples

Fujifilm Diosynth Biotechnologies commonly uses the `first.last@fujifilmdiosynth.com` email format for its employees. While this is a prevalent pattern, other formats like `firstinitiallast@fujifilmdiosynth.com` may also be in use, and variations can exist depending on the region or legacy systems from acquired entities.

first.last@fujifilmdiosynth.com

Format

jane.doe@fujifilmdiosynth.com

Example

80%

Success rate

What's the Latest News About FUJIFILM Diosynth Biotechnologies?

fujifilmdiosynth.comMay 15, 2024

Fujifilm Diosynth Biotechnologies Announces Strategic Collaboration with Selecta Biosciences to Advance ImmTOR™ Tolerogenic Nanoparticle Platform for Gene Therapy

Fujifilm Diosynth Biotechnologies and Selecta Biosciences are collaborating to advance Selecta's ImmTOR™ platform for gene therapy applications. FDB will provide CDMO services for process development and cGMP manufacturing of ImmTOR, aiming to improve the safety and efficacy of gene therapies....more

fujifilmdiosynth.comMay 1, 2024

Fujifilm Diosynth Biotechnologies and LEXEO Therapeutics Announce Strategic Collaboration to Support Manufacturing of AAV-Mediated Gene Therapies

Fujifilm Diosynth Biotechnologies and LEXEO Therapeutics have entered a strategic manufacturing collaboration. FDB will provide process development and cGMP manufacturing services for LEXEO's AAV-mediated gene therapy candidates, leveraging FDB's expertise and capacity in viral vector production....more

fujifilmdiosynth.comMarch 26, 2024

Fujifilm Diosynth Biotechnologies Initiates Cell Culture Expansion at its Large-Scale Biomanufacturing Facility in Holly Springs, North Carolina

Fujifilm Diosynth Biotechnologies has commenced its first cell culture expansion at its new, large-scale facility in Holly Springs, NC. This milestone marks a significant step towards the facility's full operational capability, which will feature 8 x 20,000L bioreactors for monoclonal antibody production....more

fujifilmdiosynth.comFebruary 27, 2024

FUJIFILM Diosynth Biotechnologies Announces the Addition of Aseptic Fill Finish Services at its Thousand Oaks, California Site

Fujifilm Diosynth Biotechnologies is expanding its capabilities by adding a new KUBio® box for aseptic fill-finish services at its Thousand Oaks, California facility. This expansion will provide flexible, high-quality drug product manufacturing for late-phase and commercial biologics....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including FUJIFILM Diosynth Biotechnologies, are just a search away.